Telmisartan: An angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telmisartan: An angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats

Published:2022-04-19 Issue:5 Volume:36 Page:869-878
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Mahmoud Mohamed Aziz¹,Safar Marwa M.²³,Agha Azza M.²,Khattab Mahmoud M.²,Saleh Dalia O.¹^ORCID

Affiliation:

1. Department of Pharmacology, Medical Division National Research Centre Giza Egypt

2. Department of Pharmacology and Toxicology, Faculty of Pharmacy Cairo University Cairo Egypt

3. Department of Pharmacology and Biochemistry, Faculty of Pharmacy The British University in Egypt Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12779

Reference41 articles.

1. Involvement of the Skeletal Renin-Angiotensin System in Age-Related Osteoporosis of Ageing Mice

2. Association between essential hypertension and bone mineral density: a systematic review and meta-analysis

3. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro

4. Physiological function of the angiotensin AT1a receptor in bone remodeling

5. Sulfur dioxide improves endothelial dysfunction by downregulating the angiotensin II/AT1R pathway in D-galactose-induced aging rats

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin–angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?;Physiological Reports;2024-06

2. Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism;Hypertension;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3